Species- and strain-level assessment using rrn long-amplicons suggests donor's influence on gut microbial transference via fecal transplants in metabolic syndrome subjects

Fecal microbiota transplantation (FMT) is currently used for treating Clostridium difficile infection and explored for other clinical applications in experimental trials. However, the effectiveness of this therapy could vary, and partly depend on the donor's bacterial species engraftment, whose evaluation is challenging because there are no cost-effective strategies for accurately tracking the microbe transference. In this regard, the precise identification of bacterial species inhabiting the human gut is essential to define their role in human health unambiguously. We used Nanopore-based device to sequence bacterial rrn operons (16S-ITS-23S) and to reveal species-level abundance changes in the human gut microbiota of a FMT trial. By assessing the donor and recipient microbiota before and after FMT, we further evaluated whether this molecular approach reveals strain-level genetic variation to demonstrate microbe transfer and engraftment. Strict control over sequencing data quality and major microbiota covariates was critical for accurately estimating the changes in gut microbial species abundance in the recipients after FMT. We detected strain-level variation via single-nucleotide variants (SNVs) at rrn regions in a species-specific manner. We showed that it was possible to explore successfully the donor-bacterial strain (e.g., Parabacteroides merdae) engraftment in recipients of the FMT by assessing the nucleotide frequencies at rrn-associated SNVs. Our findings indicate that the engraftment of donors' microbiota is to some extent correlated with the improvement of metabolic health in recipients and that parameters such as the baseline gut microbiota configuration, sex, and age of donors should be considered to ensure the success of FMT in humans. The study was prospectively registered at the Dutch Trial registry - NTR4488 (https://www.trialregister.nl/trial/4488).

Saved in:
Bibliographic Details
Main Authors: Benítez-Páez, Alfonso, Hartstra, Annick V, Nieuwdorp, Max, Sanz Herranz, Yolanda
Other Authors: European Commission
Format: artículo biblioteca
Language:English
Published: Taylor & Francis 2022-05-23
Subjects:MinION, Nanopore sequencing, Gut microbiota, rrn operon, Single-nucleotide variation, Species engraftment, Species-level resolution, http://metadata.un.org/sdg/3, Ensure healthy lives and promote well-being for all at all ages,
Online Access:http://hdl.handle.net/10261/305686
http://dx.doi.org/10.13039/501100004587
http://dx.doi.org/10.13039/501100004837
http://dx.doi.org/10.13039/501100000780
https://api.elsevier.com/content/abstract/scopus_id/85130461879
Tags: Add Tag
No Tags, Be the first to tag this record!
id dig-iata-es-10261-305686
record_format koha
spelling dig-iata-es-10261-3056862024-05-16T20:38:17Z Species- and strain-level assessment using rrn long-amplicons suggests donor's influence on gut microbial transference via fecal transplants in metabolic syndrome subjects Benítez-Páez, Alfonso Hartstra, Annick V Nieuwdorp, Max Sanz Herranz, Yolanda European Commission Ministerio de Ciencia e Innovación (España) Instituto de Salud Carlos III 0000-0001-5707-4340 0000-0002-1615-1976 MinION Nanopore sequencing Gut microbiota rrn operon Single-nucleotide variation Species engraftment Species-level resolution http://metadata.un.org/sdg/3 Ensure healthy lives and promote well-being for all at all ages Fecal microbiota transplantation (FMT) is currently used for treating Clostridium difficile infection and explored for other clinical applications in experimental trials. However, the effectiveness of this therapy could vary, and partly depend on the donor's bacterial species engraftment, whose evaluation is challenging because there are no cost-effective strategies for accurately tracking the microbe transference. In this regard, the precise identification of bacterial species inhabiting the human gut is essential to define their role in human health unambiguously. We used Nanopore-based device to sequence bacterial rrn operons (16S-ITS-23S) and to reveal species-level abundance changes in the human gut microbiota of a FMT trial. By assessing the donor and recipient microbiota before and after FMT, we further evaluated whether this molecular approach reveals strain-level genetic variation to demonstrate microbe transfer and engraftment. Strict control over sequencing data quality and major microbiota covariates was critical for accurately estimating the changes in gut microbial species abundance in the recipients after FMT. We detected strain-level variation via single-nucleotide variants (SNVs) at rrn regions in a species-specific manner. We showed that it was possible to explore successfully the donor-bacterial strain (e.g., Parabacteroides merdae) engraftment in recipients of the FMT by assessing the nucleotide frequencies at rrn-associated SNVs. Our findings indicate that the engraftment of donors' microbiota is to some extent correlated with the improvement of metabolic health in recipients and that parameters such as the baseline gut microbiota configuration, sex, and age of donors should be considered to ensure the success of FMT in humans. The study was prospectively registered at the Dutch Trial registry - NTR4488 (https://www.trialregister.nl/trial/4488). This study was supported by the EU Project MyNewGut [No. 613979] of the European Commission 7th Framework Programme and grant [PID2020-119536RB-I00] from the Ministry of Science and Innovation (Spain). This research study was also completed thanks to the [CP19/00132] grant from Miguel Servet program to ABP from the Institute of Health Carlos III (ISCIII) and its co-funding from the European Social Fund (ESF/FSE). Peer reviewed 2023-04-06T10:47:01Z 2023-04-06T10:47:01Z 2022-05-23 artículo http://purl.org/coar/resource_type/c_6501 Gut Microbes 14 (1): 2078621 (2022) 1949-0976 http://hdl.handle.net/10261/305686 10.1080/19490976.2022.2078621 http://dx.doi.org/10.13039/501100004587 http://dx.doi.org/10.13039/501100004837 http://dx.doi.org/10.13039/501100000780 35604764 2-s2.0-85130461879 https://api.elsevier.com/content/abstract/scopus_id/85130461879 en #PLACEHOLDER_PARENT_METADATA_VALUE# #PLACEHOLDER_PARENT_METADATA_VALUE# info:eu-repo/grantAgreement/EC/FP7/123456/613979 info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/PID2020-119536RB-I0 Gut microbes Publisher's version https://doi.org/10.1080/19490976.2022.2078621 Sí open Taylor & Francis
institution IATA ES
collection DSpace
country España
countrycode ES
component Bibliográfico
access En linea
databasecode dig-iata-es
tag biblioteca
region Europa del Sur
libraryname Biblioteca del IATA España
language English
topic MinION
Nanopore sequencing
Gut microbiota
rrn operon
Single-nucleotide variation
Species engraftment
Species-level resolution
http://metadata.un.org/sdg/3
Ensure healthy lives and promote well-being for all at all ages
MinION
Nanopore sequencing
Gut microbiota
rrn operon
Single-nucleotide variation
Species engraftment
Species-level resolution
http://metadata.un.org/sdg/3
Ensure healthy lives and promote well-being for all at all ages
spellingShingle MinION
Nanopore sequencing
Gut microbiota
rrn operon
Single-nucleotide variation
Species engraftment
Species-level resolution
http://metadata.un.org/sdg/3
Ensure healthy lives and promote well-being for all at all ages
MinION
Nanopore sequencing
Gut microbiota
rrn operon
Single-nucleotide variation
Species engraftment
Species-level resolution
http://metadata.un.org/sdg/3
Ensure healthy lives and promote well-being for all at all ages
Benítez-Páez, Alfonso
Hartstra, Annick V
Nieuwdorp, Max
Sanz Herranz, Yolanda
Species- and strain-level assessment using rrn long-amplicons suggests donor's influence on gut microbial transference via fecal transplants in metabolic syndrome subjects
description Fecal microbiota transplantation (FMT) is currently used for treating Clostridium difficile infection and explored for other clinical applications in experimental trials. However, the effectiveness of this therapy could vary, and partly depend on the donor's bacterial species engraftment, whose evaluation is challenging because there are no cost-effective strategies for accurately tracking the microbe transference. In this regard, the precise identification of bacterial species inhabiting the human gut is essential to define their role in human health unambiguously. We used Nanopore-based device to sequence bacterial rrn operons (16S-ITS-23S) and to reveal species-level abundance changes in the human gut microbiota of a FMT trial. By assessing the donor and recipient microbiota before and after FMT, we further evaluated whether this molecular approach reveals strain-level genetic variation to demonstrate microbe transfer and engraftment. Strict control over sequencing data quality and major microbiota covariates was critical for accurately estimating the changes in gut microbial species abundance in the recipients after FMT. We detected strain-level variation via single-nucleotide variants (SNVs) at rrn regions in a species-specific manner. We showed that it was possible to explore successfully the donor-bacterial strain (e.g., Parabacteroides merdae) engraftment in recipients of the FMT by assessing the nucleotide frequencies at rrn-associated SNVs. Our findings indicate that the engraftment of donors' microbiota is to some extent correlated with the improvement of metabolic health in recipients and that parameters such as the baseline gut microbiota configuration, sex, and age of donors should be considered to ensure the success of FMT in humans. The study was prospectively registered at the Dutch Trial registry - NTR4488 (https://www.trialregister.nl/trial/4488).
author2 European Commission
author_facet European Commission
Benítez-Páez, Alfonso
Hartstra, Annick V
Nieuwdorp, Max
Sanz Herranz, Yolanda
format artículo
topic_facet MinION
Nanopore sequencing
Gut microbiota
rrn operon
Single-nucleotide variation
Species engraftment
Species-level resolution
http://metadata.un.org/sdg/3
Ensure healthy lives and promote well-being for all at all ages
author Benítez-Páez, Alfonso
Hartstra, Annick V
Nieuwdorp, Max
Sanz Herranz, Yolanda
author_sort Benítez-Páez, Alfonso
title Species- and strain-level assessment using rrn long-amplicons suggests donor's influence on gut microbial transference via fecal transplants in metabolic syndrome subjects
title_short Species- and strain-level assessment using rrn long-amplicons suggests donor's influence on gut microbial transference via fecal transplants in metabolic syndrome subjects
title_full Species- and strain-level assessment using rrn long-amplicons suggests donor's influence on gut microbial transference via fecal transplants in metabolic syndrome subjects
title_fullStr Species- and strain-level assessment using rrn long-amplicons suggests donor's influence on gut microbial transference via fecal transplants in metabolic syndrome subjects
title_full_unstemmed Species- and strain-level assessment using rrn long-amplicons suggests donor's influence on gut microbial transference via fecal transplants in metabolic syndrome subjects
title_sort species- and strain-level assessment using rrn long-amplicons suggests donor's influence on gut microbial transference via fecal transplants in metabolic syndrome subjects
publisher Taylor & Francis
publishDate 2022-05-23
url http://hdl.handle.net/10261/305686
http://dx.doi.org/10.13039/501100004587
http://dx.doi.org/10.13039/501100004837
http://dx.doi.org/10.13039/501100000780
https://api.elsevier.com/content/abstract/scopus_id/85130461879
work_keys_str_mv AT benitezpaezalfonso speciesandstrainlevelassessmentusingrrnlongampliconssuggestsdonorsinfluenceongutmicrobialtransferenceviafecaltransplantsinmetabolicsyndromesubjects
AT hartstraannickv speciesandstrainlevelassessmentusingrrnlongampliconssuggestsdonorsinfluenceongutmicrobialtransferenceviafecaltransplantsinmetabolicsyndromesubjects
AT nieuwdorpmax speciesandstrainlevelassessmentusingrrnlongampliconssuggestsdonorsinfluenceongutmicrobialtransferenceviafecaltransplantsinmetabolicsyndromesubjects
AT sanzherranzyolanda speciesandstrainlevelassessmentusingrrnlongampliconssuggestsdonorsinfluenceongutmicrobialtransferenceviafecaltransplantsinmetabolicsyndromesubjects
_version_ 1802820533829500928